Castleman's disease;La maladie de Castleman

Revue de Medecine Interne

Volumn 17, Issue 12, 1996, Pages 1003-1013

  Larroche, C ^a   Cacoub, P ^a   Godeau, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

angiofollicular lymph node hyperplasia; Castleman's disease; interleukin 6

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CHLORMETHINE; CLADRIBINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6; PREDNISONE; VINCA ALKALOID; VINCRISTINE;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CLINICAL FEATURE; DISEASE COURSE; HISTOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW;

EID: 0030443292     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(97)80844-2     Document Type: Article

References (81)

1. 1 Castleman B, Iverson L, Menendez P. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer 1956;9:822-30
2. 2 Flendrig JA, Schillings PHM. Benign giant lymphoma. The clinical signs and symptoms. Folia Med Neerl 1969;12:119-20
3. 3 Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972;29:670-83
4. 4 Frizzera G. Castleman's disease and related disorders. Semin Diagn Pathol 1988;5:346-64
5. 5 Gaba AR, Stein RS, Sweet DL et al. Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978;69:86-90
6. 6 Weisenburger DD, Nathwani BN, Winberg CD, Rappaport H. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol 1985;16:162-72
7. 7 Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 1985;3:1202-16
8. 8 Kessler E. Multicentric giant lymph node hyperplasia. A report of seven cases. Cancer 1985;56:2446-51
9. 9 Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol 1993;20:636-47
10. 10 Nguyen DT, Diamond LW, Hansmann ML et al. Castleman's disease. Differences in follicular dendritic network in the hyaline vascular and plasma cell variants. Histopathology 1994;24:437-43
11. 11 Martin JME, Bell B, Ruether BA et al. Giant lymph node hyperplasia of hyaline vascular type. Am J Clin Pathol 1985;84:439-46
12. 12 D'Agay MF, Miclea JM, Clauvel JP et al. Castleman's disease: a well defined histological pattern for a widely divergent clinical spectrum. Nouv Rev Fr Hématol 1989;31:145-8
13. 13 Carbone A, Manconi R, Volpe R et al. Immunohistochemical, enzyme histochemical, and immunologic features of giant lymph node hyperplasia of the hyaline-vascular type. Cancer 1986;58:908-16
14. 14 Calmard-Oriol P, Billard F, Cathebras P et al. Hyperplasie angiofolliculaire de Castleman. À propos de six observations. Sem Hôp Paris 1991;67:201-6
15. 15 Delmer A, Karmochkine M, Le Tourneau A et al. Maladie de Castleman : polymorphisme clinique, biologique et évolutif. Ann Méd Interne 1990;141:123-8
16. 16 Hinaut R, Elhadad R, Hinaut G et al. Maladie de Castleman à localisation thoracique. J Radiol 1987;68:555-8
17. 17 Capdevielle P, Lapprand M, Derrien JP et al. Formes abdominales de la maladie de Castleman. Gastroentérol Clin Biol 1983;7:299-306
18. 18 Beck JT, Hsu SM, Wijdenes J et al. Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 1994;330:602-5
19. 19 Weisenburger DD, DeGowan RL, Gibson P et al. Remission of giant lymph node hyperplasia with anemia after radiotherapy. Cancer 1979;44:457
20. 20 Frizzera G, Massarelli G, Banks PM, Rosai J. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Am J Surg Pathol 1983;7:211-31
21. 21 Hall PA, Donaghy M, Cotter FE et al. An immunohistological and genotypic study of the plasma cell form of Castleman's disease. Histopathology 1989;14:333-246
22. 22 Van Den Oord JJ, De Wolf-Peeters C, Tricot G, Desmet VJ. Distribution of lymphocytes subsets in a case of angiofollicular lymph node hyperplasia. Am J Clin Pathol 1984;82:491-4
23. 23 Harris NL, Bhan AK. Plasmacytoid T cells in Castleman's disease immunohistologic phenotype. Am J Surg Pathol 1987;11:109-13
24. 24 Miller RT, Mukai K, Banks P, Frizzera G. Systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Immunoperoxidase study of cytoplasmic immunoglobulins. Arch Pathol Lab Med 1984;108:626-30
25. 25 Levo Y, Behar AJ, Blum I et al. A benign course of multicentric Castleman's disease with involvement of the spleen and bone marrow. Eur J Haematol 1987;39:471-4
26. 26 Tavoni A, Vitali C, Baglioni P et al. Multicentric Castleman's disease in a patient with primary Sjögren's syndrome. Rheum Int 1993;12:251-3
27. 27 Tsai CY, Tsai YY, Wang HTJ et al Scleroderma associated with Castleman's disease. Br J Rheumatol 1994;33:503
28. 28 Wynia MK, Shapiro B, Kuvin JT, Skolnik PR. Fatal Castleman's disease and pulmonary Kaposi's sarcoma in an HIV seropositive woman. AIDS 1995;9:814-6
29. 29 Lowenthal DA, Fillipa DA, Richardson ME, Bertoni M, Straus DJ. Generalized lymphadenopathy with morphologic features of Castleman's disease in an HIV-positive man. Cancer 1987;60:2454-8
30. 30 Lachant NA, Sun NCJ, Leong LA, Oseas RS, Prince HE. Multicentric angiofollicular lymph node hyperplasia followed by Kaposi's sarcoma in two homosexual males with the acquired immunodeficiency syndrome. Am J Clin Pathol 1985;83:27-33
31. 31 Dominguez F, Riera JR, Junco P et al. Generalized adenopathy with multicentric angiofollicular ganglionic hyperplasia in a patient with acquired immunodeficiency syndrome. Rev Clin Esp 1993;193:299-302
32. 32 Molinie V, Perie G, Melo I et al. Association de maladie de Castleman et de maladie de Hodgkin, à propos de huit cas et revue de la littérature. Ann Pathol 1994;14:384-91
33. 33 Gili A, Ngan BY, Lester R. Castleman's disease associated with pemphigus vulgaris. J Am Acad Dermatol 1991;25:955-9
34. 34 Tanaka K, Horita M, Shibayama H et al. Secondary amyloidosis associated with Castleman's disease. Intern Med 1995;34:122-6
35. 35 Radaszkiewicz T, Hansmann ML, Lennert K. Monoclonality and polyclonality of plasma cells in Castleman's disease of the plasma cell variant. Histopathology 1989;14:11-24
36. 36 Myers BM, Miralles GD, Taylor CA et al. POEMS syndrome with idiopathic flushing mimicking carcinoid syndrome. Am J Med 1991;90:646-8
37. 37 Ohyashiki JH, Ohyashiki K, Kaakubo K et al. Molecular genetic, cytogenetic, and immunophenotypic analyses in Castleman's disease of the plasma cell type. Am J Clin Pathol 1994;101:290-5
38. 38 Nakamura H, Nakaseko C, Ishii A et al. Chromosomal abnormalities in Castleman's disease with high levels of serum interleukin-6 [Abstract]. Jpn J Clin Hematol 1993;34:212-7
39. 39 Hanson CA, Frizzera G, Patton DF et al. Clonal rearrangement for immunoglobulin and T-cell receptor genes in systemic Castleman's disease. Association with Epstein-Barr virus. Am J Pathol 1988;131:84-91
40. 40 Nagai M, Irino S, Uda H et al. Molecular genetic and immunohistochemical analyses of a case of multicentric Castleman's disease. Jpn J Clin Oncol 1988;18:149-57
41. 41 Soulier J, Grollet L, Oksenhendler E et al. Molecular analysis of clonality in Castleman's disease. Blood 1995;86:1131-8
42. 42 Del Rio R, Alsina M, Monteagudo J et al. POEMS syndrome and multiple angioproliferative lesions mimicking generalized histiocytomas. Acta Dermato-Venereol 1994;74:388-90
43. 43 Kubota Y, Noto S, Takakuwa T et al. Skin involvement in giant lymph node hyperplasia. J Am Acad Dermatol 1993;29:778-80
44. 44 Dickson D, Ben-Ezra J, Reed J et al. Multicentric giant lymph node hyperplasia, Kaposi's sarcoma, and lymphoma. Arch Pathol Lab Med 1985;109:1013-8
45. 45 Sherman D, Ramsay B, Theodorou NA et al. Reversible plane xanthoma, vasculitis, and peliosis hepatitis in giant lymph node hyperplasia: a case report and review of the cutaneous manifestations of giant lymph node hyperplasia. J Am Acad Dermatol 1992;26:105-9
46. 46 Torii K, Kawabata Y, Yokoi T et al. Lymphoid interstitial pneumonia as a pulmonary lesion of idiopathic plasmacytic lymphadenopathy with hyperimmunoglobulinemia. Intern Med 1994;33:237-41
47. 47 Sato T, Wakabayashi Y, Hirasawa A et al. Multicentric Castleman's disease accompanied with both lymphoid interstitial pneumonia and interstitial nephritis [Abstract]. Jpn J Clin Hematol 1994;35:1322-8
48. 48 Moss SF, Thomas DM, Mulnier C et al. Intestinal lymphangiectasia associated with angiofollicular lymph node hyperplasia. Gut 1992;33:135-7
49. 49 Oksenhendler E, Dell'Isola B, Chomette G. Confrontation anatomoclinique : fièvre prolongée, polyneuropathie et diabète chez un homme de 50 ans. Ann Méd Intern 1991;142:276-82
50. 50 Adelman HM, Cacciatore ML, Pascual JF et al. Case report: Castleman's disease in association with POEMS. Am J Med Sci 1994;307:112-4
51. 51 Gould J, Diss T, Isaacson PG. Multicentric Castleman's disease in association with a solitary plasmocytoma: a case report. Histopathology 1990;17:135-40
52. 52 Said R, Tarawneh M. Membranoproliferative glomerulonephritis associated with multicentric angiofollicular lymph node hyperplasia. Am J Nephrol 1992;12:466-70
53. 53 Chan TM, Cheng IKP, Wong KL et al. Resolution of membranoproliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia. Nephron 1993;65:628-32
54. 54 Kingsmore SF, Silva OE, Hall BD et al. Presentation of multicentric Castleman's disease with Sicca syndrome, cardiomyopathy, palmar and plantar rash. J Rheumatol 1993;20:1588-91
55. 55 Nanki T, Tomiyama J, Arai S. Mixed connectivite tissue disease associated with multicentric Castleman's disease. Scand J Rheumatol 1994;23:215-7
56. 56 Hosaka S, Kondo H. Three cases of Castleman's disease mimicking the features of collagen disease. Ryumachi 1994;34:42-7
57. 57 Crump JA, Beard MEJ, Angus HB et al. Acute adrenal insufficiency, a new presentation of Castleman's disease. J Intern Med 1995;238:81-4
58. 58 Carrington PA, Anderson H, Harris M et al. Autoimmune cytopenias in Castleman's disease. Am J Clin Pathol 1990;94:101-4
59. 59 Diebold J, Tulliez M, Bernadou A et al. Angiofollicular and plasmacytic polyadenopathy: a pseudotumourous syndrome with dysimmunity. J Clin Pathol 1980;33:1068-76
60. 60 Ishiyama T, Nakamura S, Akimoto Y et al. Immunodeficiency and IL6 production by peripheral blood monocytes in multicentric Castleman's disease. Br J Haematol 1994;86:483-9
61. 61 Kishimoto T. The biology of interleukin-6. Blood 1989;74:1-10
62. 62 Bartoli E, Massarelli G, Soggia G et al. Multicentric giant lymph node hyperplasia. A hyperimmune syndrome with a rapidly progressive course. Am J Clin Pathol 1980;73:423-6
63. 63 Moir DH, Choy T, Dalton WR. Giant lymph node hyperplasia. Persistence of symptoms for 15 years. Cancer 1982;49:748-50
64. 64 Soulier J, Grollet L, Oksenhendler E et al. Kaposi's sarcoma-associated Herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995;86:1276-80
65. 65 Summerfield GP, Taylor W, Bellingham AJ et al. Hyaline-vascular variant of angiofollicular lymph node hyperplasia with systemic manifestations and response to corticosteroids. J Clin Pathol 1983;36:1005-11
66. 66 Herrada J, Cabanillas FF. Multicentric Castleman's disease. Am J Clin Oncol 1995;18:180-3
67. 67 Pavlidis NA, Briassoulis E, Klouvas G et al. Is interferon α an active agent in Castleman's disease? Ann Oncol 1992;3:85-6
68. 68 Tamayo M, Gonzalez C, Majado MJ, Candel R. Long-term complete remission after interferon treatment in a case of multicentric Castleman's disease. Am J Haematol 1995;49:359-60
69. 69 Marti S, Pahissa A, Guardia J et al. Multicentric giant follicular lymph node hyperplasia. Favourable response to radiotherapy. Cancer 1983;51:808-10
70. 70 Bordeleau L, Bredeson C, Markman S. 2-chloro-deoxyadenosine therapy for giant lymph node hyperplasia. Br J Haematol 1995;91:668-70
71. 71 Suematsu S, Matsuda T, Aozasa K et al. IgG1 plasmocytosis in interleukin-6 transgenic mice. Proc Natl Acad Sci USA 1989;86:7547-51
72. 72 Yoshizaki K, Kuritani T, Kishimoto T. Interleukin-6 in autoimmune disorders. Semin Immunol 1992;4:155-66
73. 73 Brandt SJ, Bodine DM, Dunbar CE et al. Dysregulate interleukin-6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 1990;86:592-9
74. 74 Screpanti I, Romani L, Musiani P et al. Lymphoproliferative disorder and imbalanced T-helper response in C/EBPβ-deficient mice. EMBO J 1995;14:1932-41
75. 75 Yoshizaki K, Matsuda T, Nishimoto N et al. Pathogenic significance of interleukin-6 in Castleman's disease. Blood 1989;74:1360-7
76. 76 Leger-Ravet MB, Peuchmaur M, Devergne O et al. Interleukin-6 gene expression in Castleman's disease. Blood 1991;78:2923-30
77. 77 Hsu SM, Waldron JA, Xie SS, Barlogie B. Expression of interleukin-6 in Castleman's disease. Hum Pathol 1993;24:833-9
78. 78 Emilie D, Galanaud P. Cytokines et auto-immunité. Rev Prat (Paris) 1994;44:28-31
79. 79 Krishnan J, Danon AD, Frizzera G. Reactive lymphadenopathies and atypical lymphoproliferative disorders. Am J Clin Pathol 1993;99:385-96
80. 80 Samoszuk M, Ramzi E, Ravel J. Disseminated persistent lymphoid hyperplasia containing Epstein-Barr virus and clonal rearrangements of DNA. Diagn Mol Pathol 1993;2:57-60
81. 81 Vellutini C, Horschowski N, Philippon V et al. Development of lymphoid hyperplasia in transgenic mice expressing the HIV tat gene. AIDS Res Hum Retrov 1995;11:21-9